Navigation Links
HIV sufferers need hepatitis safeguards
Date:3/27/2013

Stronger protections are needed to prevent people with HIV from also becoming infected with hepatitis, researchers argue in a new study led by Michigan State University.

Behaviors that put people at higher risk of contracting HIV sharing needles, having unprotected sex or getting blood transfusions, for instance also raise their risk of getting hepatitis B or C, diseases that attack the liver and, if untreated, can be deadly.

The study, which included all registered cases of HIV in Michigan, found about four percent of HIV-positive people also had hepatitis. That's less than some previous studies have found elsewhere, but it still represents a significant public health concern, said Zahid Butt, who led the research as a doctoral student in MSU's Department of Epidemiology and Biostatistics.

"Ultimately, because of the fact that they're suffering from two diseases, they're more likely to die than if they only have one," said Butt, who now runs the epidemiology division of a public health institute in Islamabad, Pakistan.

For example, having HIV more than triples the risk of liver disease, liver failure and liver-related death among individuals who also have hepatitis C, according to the Centers for Disease Control and Prevention.

The researchers found the highest rate of co-infection among males, particularly those who marked their race as "other," which included anything other than white, black or Hispanic. Butt said that was surprising, since previous studies have found African American men were at highest risk for co-infection.

"It could be that we're getting a cohort of people who were not vaccinated in childhood because they're coming from countries that don't require vaccination," he said. "It also may be that some marginalized groups might not get vaccinated because they don't trust the health care system."

Butt said all states should require children to be vaccinated against hepatitis B whe
'/>"/>

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Hope on the horizon for asthma sufferers
2. Computer modeling reveals how surprisingly potent hepatitis C drug works
3. Virology researcher awarded nearly $2 million to study chronic hepatitis E
4. In a fight to the finish, Saint Louis University research aims knockout punch at hepatitis B
5. Teens susceptible to hepatitis B infection despite vaccination as infants
6. Molecular and protein markers discovered for liver transplant failure from hepatitis C
7. Height, weight and BMI changes seen in children treated with peginterferon alpha for hepatitis C
8. Levels of hepatitis C virus higher among African-Americans and males
9. ACRG and BGI report findings from genomics research on recurrent hepatitis B virus integration
10. Recapitulation of the entire hepatitis C virus life in engineered mouse cell lines
11. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool ... toward a healthier, happier life. That,s exactly what USANA,s ... to do. The cutting-edge, portable health program provides a ... solutions to help improve your lifestyle and nutrition. ... dinner and gala Wednesday night, USANA,s THA was honored ...
(Date:6/24/2015)... , June 22, 2015 ... announced the addition of the "Huawei Ascend ... report to their offering. Huawei,s ... to the opposite direction than Apple,s and Samsung,s ... fingerprint sensor developed by Fingerprint Cards, a main ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... the Advancement of Science (AAAS) has named Dr. J. ... University of Colorado School of Medicine, as winner of ... Award., Cohen was honored for his outstanding achievements in ... series of free lectures on science and medicine, informal ...
... ANN ARBOR, Mich.---Rising carbon dioxide levels associated with global ... that eat them, altering the course of plant evolution, ... The research focused on the effects of elevated carbon ... of many plants that produce toxic or bitter chemical ...
... short stature is not usually cause for concern, but it ... syndrome. Prevalent in girls, Turner syndrome is a genetic defect ... problems. It is not commonly detected until age 10 or ... This lag before diagnosis of the condition can delay ...
Cached Biology News:Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 2Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 3Immunologist J. John Cohen receives the 2010 AAAS Public Understanding of Science and Technology Award 4Global warming may reroute evolution 2New test shows promise for accurate diagnosis of Turner syndrome 2
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
(Date:7/30/2015)... July 30, 2015 HIGHLIGHTS:Q2 2015 ... 2014) , Reported sales were $697 million compared ... Sales grew organically by 8%, and changes in foreign ... increased sales by 1%. , By business unit, ... Applied and 11% in SAFC Commercial. , Reported ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ ... for continuous operation up to 1500 bar. The sanitary design gauge of the ... toxic contamination. , The Pony™ NS2006L homogenizer is an ideal solution for the ...
(Date:7/29/2015)... -- According to a new market research report, ... (2015-2020), , published by Mordor Intelligence, the Global market is ... of 2020, with North America being ... the global market size. The Global market for Stem Cells ... the period of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3
... Tumor Protection In Vivo; Lead Candidate May Have Utility ... ... SAN DIEGO, CA, Sept. 24 /PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals Corporation ... lead therapeutic vaccine candidate for the treatment,of human papillomavirus (HPV)-related ...
... Detection of HPV Viral Load a Possible Indicator of Cervical ... ... Sept. 24 Cepheid (Nasdaq:,CPHD) today announced that it has entered ... held by Quantovir,AB of Sweden for the quantitative measurement of high-risk ...
... September 24 ProImmune Ltd., a leading,provider of quality ... antigen discovery, has announced the launch of its new,MHC-peptide ... the series of,discovery services for Class I HLA already ... binding assay for HLA alleles DR1-4, is a,powerful cell-free ...
Cached Biology Technology:Nventa announces publication of HspE7 data 2Nventa announces publication of HspE7 data 3Nventa announces publication of HspE7 data 4Nventa announces publication of HspE7 data 5Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 2Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 3Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB 4ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles 2
FEN-1 (B-4)...
Secure-Seal™ spacer, one well, 20 mm diameter, 0.12 mm deep *set of 100*...
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells....
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
Biology Products: